Grappling with adherence, risk, and efficacy is a central problem of HIV PrEP public health policy. How have these (often contested) concepts been informed by two decades of PrEP clinical research? My new paper in Social Studies of Science: https://doi.org/10.1177/0306312720933943

Homo adhaerens: Risk and adherence in biomedical HIV prevention research
Leave a reply